id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0231-0007,FDA,FDA-2011-N-0231,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Adverse
Experience Reporting for Licensed Biological Products; and General
Records",Notice,30 Day Proposed Information Collection,2014-10-29T04:00:00Z,2014,10,2014-10-29T04:00:00Z,2014-11-29T04:59:59Z,2014-11-28T03:00:48Z,2014-25637,0,0,0900006481905358
FDA-2011-N-0231-0005,FDA,FDA-2011-N-0231,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Adverse Experience Reporting for Licensed
Biological Products; and General Records",Notice,60 Day Proposed Information Collection,2014-04-07T04:00:00Z,2014,4,2014-04-07T04:00:00Z,2014-06-07T03:59:59Z,2014-10-16T21:34:25Z,2014-07711,0,0,09000064816a301b